Unipharm Plavix Ruling May Change Game On Recouping Lost Generics Profits In Israel
‘Plots Are Yet To Be Prepared For Us,’ Admits Israeli Supreme Court In Precedential Ruling
In a much watched and controversial case that may have significant ramifications on the “chilling effects” of generics manufacturers in Israel being deterred from chasing after approvals in which an originator has deceitfully sought to ‘evergreen’ its branded intellectual property, the Israeli Supreme Court has once again come down on the side of the generics industry.
